Ko, Youme
Sun, Seung-Ho
Han, In-Sik
Go, Ho-Yeon
Kim, Tae-Hun
Lee, Jin-Moo
Jang, Jun-Bok
Park, Kyoung Sun
Song, Yun-Kyung
Lee, Kyou-Young
Jeon, Chan-Yong
Ko, Seong-Gyu
Funding for this research was provided by:
Ministry of Health and Welfare (HI13C0530)
Article History
Received: 7 January 2019
Accepted: 11 March 2019
First Online: 15 April 2019
Ethics approval and consent to participate
: This trial has been approved by the IRBs of five hospitals (Gachon University Gil Korean Medical Hospital: 17–105, Kyung Hee University Oriental Medical Center: KOMCIRB-171117-HR-048-03, Kyung Hee University Korean Medicine Hospital at Gangdong: KHNMCOH2017–11-004, Korean Medical Hospital of Sangji University: SJIRB-17-001, and Semyung University Second Affiliated Korean Medical Hospital at Chungju: 1711–18). The study will be performed according to the Helsinki Declaration and the Good Clinical Practice Guidelines of the Korea Food and Drug Administration. Written informed consent will be obtained from all subjects prior to any clinical trial procedures. If any issue which may have impacted to the performance of the trial is occurred, it should be approved by the site IRB prior to implementation. After the site approval, each site staffs must be notified and trained before conducting the trial.The results of the trial will be disseminated through scientific journals or presentations at scientific conferences. So far, the public access to any trial data set is still unplanned.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.